Overview

Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients With Chronic Kidney Disease

Status:
Not yet recruiting

Trial end date:
2025-04-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the effects of dapagliflozin on echocardiographic measures of cardiac structure and function in patients with chronic kidney disease.

Phase:

Phase 2

Details

Lead Sponsor:

Tor Biering-Sørensen

Treatments:

Dapagliflozin